Palladium-103 Market - Global Forecast 2026-2032

The Palladium-103 market is undergoing significant transformation as healthcare providers and industry stakeholders demand robust solutions tailored to clinical workflow integration and operational dependability. Senior decision-makers must closely monitor market dynamics to ensure alignment with evolving regulatory, supply chain, and care delivery requirements across global oncology landscapes.

Market Snapshot: Palladium-103 Market Size and Growth

The global Palladium-103 market is exhibiting strong momentum, expanding from USD 1.18 billion in 2025 to USD 1.30 billion in 2026 and forecast to reach USD 2.56 billion by 2032, supported by a CAGR of 11.71%. Key drivers include advancements in brachytherapy seed technology, heightened demand for precision in cancer care, and the shift toward value-based healthcare delivery. Hospitals and specialty clinics continue to lead adoption, leveraging new reimbursement structures and streamlined supply chain models to maximize clinical efficiency and enhance patient outcomes.

Palladium-103 Market Scope & Segmentation

Product Types: The market includes brachytherapy seeds, upstream isotope supply, irradiation services, seed manufacturing and sterilization, and value-added clinical planning tools, providing a complete ecosystem for procedure implementation.
Applications: Prostate brachytherapy anchors the segment, supplemented by uses in ophthalmic, head-and-neck, and investigational therapies, each necessitating multidisciplinary collaboration and protocol adherence.
End-Users: Hospitals, specialty clinics, and academic or research institutions each demand precise inventory management, regulatory compliance, and rapid technical assistance, influencing their partnership strategies.
Distribution Channels: Direct-to-provider supply and distributor-enabled channels shape procurement approaches, impacting efficiency, safety compliance, and radiation logistics oversight.
Dose Strength & Configuration: Flexible strengths and seed configurations, alongside integration with digital treatment planning systems, enable personalized care within standardized oncological pathways.
Regions: The Americas; Europe, Middle East, and Africa; and Asia-Pacific regions, distinguished by their health system maturity, regulatory frameworks, and logistics infrastructure, each presenting varying opportunities and barriers to adoption.
Technology Use: Advanced imaging, dosimetric planning, supply-chain automation, and quality control solutions are embedded across production and clinical workflows, reinforcing accuracy and safety at every stage.

Palladium-103: Key Takeaways for Senior Decision-Makers

A resilient and integrated supply chain is fundamental, with market positioning closely tied to supporting urgent and predictable clinical schedules.
Service models are evolving, as healthcare organizations increasingly value supplier support in training, workflow integration, and real-time planning collaboration for oncology teams.
Regulatory discipline, especially around quality documentation and batch management, is central to maintaining provider confidence and minimizing procedure disruption.
Competition from alternative isotopes and external beam modalities is intensifying; workflow integration and measurable clinical support are essential for differentiation.
Regional adoption is shaped by differences in infrastructure, clinical expertise, regulatory pathways, and access to compliant logistics and radiation-handling resources.

Tariff Impact on the Palladium-103 Supply Chain

The 2025 implementation of United States tariffs is influencing both cost structures and risk management throughout the global Palladium-103 supply chain. Tariffs impact not only direct isotope imports but also the procurement of specialized metals, packaging, and supporting components, leading to increased expenses and complexity. These factors disrupt lead time predictability and drive a reliance on buffer stocks for non-radioactive materials, while radioactive inventory remains less flexible for traditional buffering strategies. As a result, suppliers are prioritizing qualification of partners and optimizing vendor selection, while buyers explore longer-term supply agreements and cost stabilization mechanisms. Vertical integration and regional manufacturing have become increasingly valuable, as they help mitigate duty exposure and bolster resilience under global supply disruptions.

Methodology & Data Sources

This analysis is grounded in a triangulated methodology, combining direct interviews with isotope producers, brachytherapy device manufacturers, and clinical leaders with secondary research into regulatory developments, technology trends, and supply chain structures. Comprehensive value-chain mapping tracks the journey from material sourcing to final device delivery, exposing operational dependencies and strategic risk points.

Why This Report Matters for Decision-Makers

Equips leaders with actionable guidance for aligning operational strategies to supply, regulatory, and workflow developments across key markets.
Highlights competitive and technological trends relevant for sustaining viable oncology programs and improving reliability in clinical scheduling.
Facilitates proactive risk mitigation by assessing tariff impacts, regulatory shifts, and supply chain vulnerabilities, empowering more informed procurement and partnership decisions.

Conclusion

Organizations that prioritize workflow-integrated support and operational reliability in the Palladium-103 market are best positioned to foster provider trust, reduce supply chain risks, and maintain a strategic edge as oncology service models advance.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Palladium-103 Market, by Application

8.1. Prostate Cancer
8.2. Uveal Melanoma

9. Palladium-103 Market, by Source Form

9.1. Liquid Source
9.2. Seed Source

10. Palladium-103 Market, by End User

10.1. Ambulatory Surgical Centers
10.2. Hospitals
10.3. Oncology Clinics

11. Palladium-103 Market, by Packaging Type

11.1. Loose Seeds
11.2. Preloaded Applicators

12. Palladium-103 Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Palladium-103 Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Palladium-103 Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Palladium-103 Market
16. China Palladium-103 Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Becton, Dickinson and Company
17.6. Best Medical International, Inc.
17.7. Brachytherapy Services, Inc.
17.8. BuyIsotope
17.9. Cyclotron ZAO
17.10. Eckert & Ziegler BEBIG GmbH
17.11. Eckert & Ziegler SE
17.12. International Brachytherapy SA
17.13. IsoAid, LLC
17.14. JSC Isotope
17.15. Nordion Inc.
17.16. NTP Radioisotopes (Pty) Ltd
17.17. SeeDOS Ltd.
17.18. Theragenics Corporation
17.19. VonBV, Inc.

List of Figures

FIGURE 1. GLOBAL PALLADIUM-103 MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PALLADIUM-103 MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PALLADIUM-103 MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PALLADIUM-103 MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PALLADIUM-103 MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PALLADIUM-103 MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES PALLADIUM-103 MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA PALLADIUM-103 MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL PALLADIUM-103 MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PALLADIUM-103 MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PALLADIUM-103 MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PALLADIUM-103 MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PALLADIUM-103 MARKET SIZE, BY UVEAL MELANOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PALLADIUM-103 MARKET SIZE, BY UVEAL MELANOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PALLADIUM-103 MARKET SIZE, BY UVEAL MELANOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PALLADIUM-103 MARKET SIZE, BY LIQUID SOURCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PALLADIUM-103 MARKET SIZE, BY LIQUID SOURCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PALLADIUM-103 MARKET SIZE, BY LIQUID SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PALLADIUM-103 MARKET SIZE, BY SEED SOURCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PALLADIUM-103 MARKET SIZE, BY SEED SOURCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PALLADIUM-103 MARKET SIZE, BY SEED SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PALLADIUM-103 MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PALLADIUM-103 MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PALLADIUM-103 MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PALLADIUM-103 MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PALLADIUM-103 MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PALLADIUM-103 MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PALLADIUM-103 MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PALLADIUM-103 MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PALLADIUM-103 MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PALLADIUM-103 MARKET SIZE, BY LOOSE SEEDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PALLADIUM-103 MARKET SIZE, BY LOOSE SEEDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PALLADIUM-103 MARKET SIZE, BY LOOSE SEEDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PALLADIUM-103 MARKET SIZE, BY PRELOADED APPLICATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PALLADIUM-103 MARKET SIZE, BY PRELOADED APPLICATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PALLADIUM-103 MARKET SIZE, BY PRELOADED APPLICATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PALLADIUM-103 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. AMERICAS PALLADIUM-103 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 35. AMERICAS PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 36. AMERICAS PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 37. AMERICAS PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 38. AMERICAS PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 39. NORTH AMERICA PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. NORTH AMERICA PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 41. NORTH AMERICA PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 42. NORTH AMERICA PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 43. NORTH AMERICA PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 44. LATIN AMERICA PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. LATIN AMERICA PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 46. LATIN AMERICA PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 47. LATIN AMERICA PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 48. LATIN AMERICA PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA PALLADIUM-103 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 54. EUROPE PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. EUROPE PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 56. EUROPE PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 57. EUROPE PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 58. EUROPE PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 59. MIDDLE EAST PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. MIDDLE EAST PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 61. MIDDLE EAST PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 62. MIDDLE EAST PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 63. MIDDLE EAST PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 64. AFRICA PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. AFRICA PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 66. AFRICA PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 67. AFRICA PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. AFRICA PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 69. ASIA-PACIFIC PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PALLADIUM-103 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. ASEAN PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. ASEAN PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 77. ASEAN PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 78. ASEAN PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. ASEAN PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 80. GCC PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GCC PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. GCC PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 83. GCC PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. GCC PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 85. EUROPEAN UNION PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. EUROPEAN UNION PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. EUROPEAN UNION PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 88. EUROPEAN UNION PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. EUROPEAN UNION PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 90. BRICS PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. BRICS PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. BRICS PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 93. BRICS PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. BRICS PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 95. G7 PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. G7 PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. G7 PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 98. G7 PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. G7 PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 100. NATO PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. NATO PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. NATO PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 103. NATO PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. NATO PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. UNITED STATES PALLADIUM-103 MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 107. UNITED STATES PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. UNITED STATES PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 109. UNITED STATES PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. UNITED STATES PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 111. CHINA PALLADIUM-103 MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 112. CHINA PALLADIUM-103 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. CHINA PALLADIUM-103 MARKET SIZE, BY SOURCE FORM, 2018-2032 (USD MILLION)
TABLE 114. CHINA PALLADIUM-103 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. CHINA PALLADIUM-103 MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Palladium-103 market report include:

Becton, Dickinson and Company
Best Medical International, Inc.
Brachytherapy Services, Inc.
BuyIsotope
Cyclotron ZAO
Eckert & Ziegler BEBIG GmbH
Eckert & Ziegler SE
International Brachytherapy SA
IsoAid, LLC
JSC Isotope
Nordion Inc.
NTP Radioisotopes (Pty) Ltd
SeeDOS Ltd.
Theragenics Corporation
VonBV, Inc.

Table Information

Report Attribute	Details
No. of Pages	193
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 1.3 Billion
Forecasted Market Value ( USD ) by 2032	$ 2.56 Billion
Compound Annual Growth Rate	11.7%
Regions Covered	Global
No. of Companies Mentioned	16

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3451EUR$3,939USD£2,978GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3723EUR$4,249USD£3,212GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5046EUR$5,759USD£4,354GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6106EUR$6,969USD£5,269GBP

Market Snapshot: Palladium-103 Market Size and Growth

Palladium-103 Market Scope & Segmentation

Palladium-103: Key Takeaways for Senior Decision-Makers

Tariff Impact on the Palladium-103 Supply Chain

Methodology & Data Sources

Why This Report Matters for Decision-Makers

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Reagent Grade Palladium Bromide Market - Global Forecast 2026-2032

Palladium Market - Global Forecast 2026-2032

Palladium Market Outlook 2026-2034: Market Share, and Growth Analysis

Palladium on Calcium Carbonate Catalyst Market Report: Trends, Forecast and Competitive Analysis to 2031

Palladium Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)